EpiPen Dosage Based on Patient Weight
For patients weighing 15-30 kg (33-66 lbs), administer EpiPen Jr 0.15 mg; for patients weighing ≥30 kg (≥66 lbs), administer EpiPen 0.3 mg intramuscularly into the anterolateral thigh. 1
Weight-Based Dosing Algorithm
The FDA-approved EpiPen dosing is straightforward and weight-based:
This aligns with the 2015 American Heart Association/American Red Cross guidelines, which recommend 0.15 mg intramuscularly for children 15-30 kg and 0.3 mg for adults and children >30 kg 2, 3. The NIAID-sponsored 2010 guidelines similarly specify 0.15 mg for weight 10-25 kg and 0.3 mg for weight ≥25 kg 4, 5, 4.
Administration Technique
Inject intramuscularly into the anterolateral thigh (vastus lateralis muscle), through clothing if necessary. 1 This route provides more rapid plasma epinephrine concentrations compared to subcutaneous injection 5. The needle must be long enough to reach muscle beneath subcutaneous fat—a critical consideration given that 12% of children <30 kg and 30% of children ≥30 kg may have skin-to-muscle distances exceeding current needle lengths 6.
For young children who may be uncooperative, caregivers must firmly hold the leg in place to prevent movement during injection and avoid inadvertent needle injuries 1.
Special Populations and Dosing Considerations
Infants and Children <15 kg
For children weighing <15 kg, the 0.15 mg EpiPen Jr is recommended despite exceeding the ideal 0.01 mg/kg dose 7. The Canadian Society of Allergy and Clinical Immunology states that adverse effects from this dose are expected to be mild and transient, and must be weighed against the potentially fatal consequences of not receiving epinephrine 7. A newer 0.1 mg autoinjector is available for infants 7.5-15 kg, providing better dosing accuracy 8, 9.
Patients ≥45 kg
For patients weighing ≥45 kg, the standard 0.3 mg dose may result in underdosing (falling below the 0.01 mg/kg recommendation). The Canadian Society recommends considering a 0.5 mg autoinjector for patients ≥45 kg based on shared decision-making 10. However, the FDA-approved EpiPen only comes in 0.15 mg and 0.3 mg doses 1.
Repeat Dosing
If anaphylaxis persists or recurs, repeat the dose after 5-15 minutes. 4, 5, 4 Studies show 10-20% of patients require more than one dose 5. More than two sequential doses should only be administered under direct medical supervision 1. Each autoinjector is single-use only; approximately 1.7 mL of the 2 mL solution remains in the device after activation but is not available for reuse 1.
Critical Pitfalls to Avoid
- Never delay epinephrine administration—delayed epinephrine has been implicated in anaphylaxis fatalities 4
- Do not inject intravenously—this can cause cerebral hemorrhage from sharp blood pressure rise 1
- Do not inject into buttocks, digits, hands, or feet 1
- Do not substitute antihistamines or bronchodilators for epinephrine—these are adjunctive only 4, 5, 4
- Always proceed to emergency facility after epinephrine administration for 4-6 hours observation, even if symptoms resolve 4
Post-Treatment Management
All patients discharged after anaphylaxis treatment should receive: (1) an anaphylaxis emergency action plan, (2) two epinephrine autoinjectors, (3) a plan for monitoring expiration dates, and (4) arrangements for further evaluation 4.